Understanding current and past BHARAT IMMUNOLOGICALS Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions.
We suggest to use BHARAT IMMUNOLOGICALS BIOLOG fundamental analysis to find out if markets are at this time mispricing the company. Strictly speaking you can use it to find out if BHARAT IMMUNOLOGICALS is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to break down and interpolate twenty-three available financial indicators for BHARAT IMMUNOLOGICALS, which can be compared to its peers in the sector. To make sure the equity is not overpriced, please confirm all BHARAT IMMUNOLOGICALS BIOLOG financials, including its operating margin, revenue, debt to equity, as well as the relationship between the price to earning and net income .

Search Fundamentals 

With this module, you can analyze BIBCL BHARAT financials for your investing period. You should be able to track the changes in BHARAT IMMUNOLOGICALS individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  Chance Of Financial Distress
Less than 49
BHARAT IMMUNOLOGICALS BIOLOG has less than 49 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for BHARAT IMMUNOLOGICALS stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in BHARAT IMMUNOLOGICALS's official financial statements usually reflect BHARAT IMMUNOLOGICALS's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of BHARAT IMMUNOLOGICALS. For example, before you start analyzing numbers published by BIBCL BHARAT accountants, it's critical to develop an understanding of what BHARAT IMMUNOLOGICALS's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of BHARAT IMMUNOLOGICALS's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BHARAT IMMUNOLOGICALS's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in BHARAT IMMUNOLOGICALS's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of BHARAT IMMUNOLOGICALS BIOLOG. Please utilize our Beneish M Score to check the likelihood of BHARAT IMMUNOLOGICALS's management to manipulate its earnings.


BHARAT IMMUNOLOGICALS competes with Baroda ELSS. Bharat Immunologicals Biologicals Corporation Limited, a biotechnology company, manufactures and markets a range of pharmaceuticals products in India. The company was founded in 1989 and is based in Bulandshahr, India. BHARAT IMMUNOLOGICALS operates under Biotechnology classification in India and is traded on Bombay Stock Exchange.
InstrumentIndia Stock View All
ExchangeBombay Stock Exchange
Business AddressOPV Plant
Phone91 57 3223 8757


Generally speaking, BHARAT IMMUNOLOGICALS's financial ratios allow both analysts and investors to convert raw data from BHARAT IMMUNOLOGICALS's financial statements into concise, actionable information that can be used to evaluate the performance of BHARAT IMMUNOLOGICALS over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that BHARAT IMMUNOLOGICALS reports annually and quarterly.

BIBCL BHARAT Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining BHARAT IMMUNOLOGICALS's current stock value. Our valuation model uses many indicators to compare BHARAT IMMUNOLOGICALS value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BHARAT IMMUNOLOGICALS competition to find correlations between indicators driving BHARAT IMMUNOLOGICALS's intrinsic value. More Info.
BHARAT IMMUNOLOGICALS BIOLOG is number one stock in return on asset category among related companies. It is number one stock in operating margin category among related companies .
Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Check out Trending Equities. Note that the BHARAT IMMUNOLOGICALS information on this page should be used as a complementary analysis to other BHARAT IMMUNOLOGICALS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Tools for BIBCL BHARAT stock

When running BHARAT IMMUNOLOGICALS price analysis, check to measure BHARAT IMMUNOLOGICALS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BHARAT IMMUNOLOGICALS is operating at the current time. Most of BHARAT IMMUNOLOGICALS's value examination focuses on studying past and present price action to predict the probability of BHARAT IMMUNOLOGICALS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move BHARAT IMMUNOLOGICALS's price. Additionally, you may evaluate how the addition of BHARAT IMMUNOLOGICALS to your portfolios can decrease your overall portfolio volatility.
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Equity Search
Search for activelly-traded equities including funds and ETFs from over 30 global markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios